$CNFN
CFN Enterprises Inc. Stock $cnfn

$cnfn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000109690624001665 Filed on August 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$6.772M	$5.894M
YoY Change	303.42%	3769.94%
Cost Of Revenue	$2.395M	$4.878M
YoY Change	95.42%	10172.94%
Gross Profit	$4.377M	$1.016M
YoY Change	866.09%	869.27%
Gross Profit Margin	64.63%	17.24%
Selling, General & Admin	$2.740M	$1.547M
YoY Change	71.52%	-9.17%
% of Gross Profit	62.61%	152.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.16K	$9.478K
YoY Change	-77.58%	234.79%
% of Gross Profit	0.23%	0.93%
Operating Expenses	$2.740M	$1.547M
YoY Change	71.52%	-9.17%
Operating Profit	$1.636M	-$531.0K
YoY Change	-242.96%	-66.78%
Interest Expense	$663.5K	$720.4K
YoY Change	-13.37%	1823.7%
% of Operating Profit	40.55%
Other Income/Expense, Net	-$663.5K	-$720.4K
YoY Change	-13.37%	-605.14%
Pretax Income		-$1.251M
YoY Change		-14.04%
Income Tax
% Of Pretax Income
Net Earnings	$972.9K	-$1.251M
YoY Change	-150.92%	-14.04%
Net Earnings / Revenue	14.37%	-21.23%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.02
COMMON SHARES
Basic Shares Outstanding	82.21M shares	82.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$225.4K
YoY Change		-78.49%
Cash & Equivalents	$263.7K	$225.4K
Short-Term Investments
Other Short-Term Assets		$20.60K
YoY Change		1.58%
Inventory	$4.237M	$1.865M
Prepaid Expenses
Receivables	$2.360M	$1.701M
Other Receivables		$0.00
Total Short-Term Assets	$6.861M	$3.811M
YoY Change	55.45%	245.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$167.6K	$164.4K
YoY Change	1.7%	243.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$297.3K
YoY Change
Other Assets		$8.810K
YoY Change		-84.18%
Total Long-Term Assets	$9.052M	$6.142M
YoY Change	-43.39%	315.92%
TOTAL ASSETS
Total Short-Term Assets	$6.861M	$3.811M
Total Long-Term Assets	$9.052M	$6.142M
Total Assets		$6.142M
YoY Change		315.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.794M	$4.440M
YoY Change	132.96%	91.54%
Accrued Expenses	$6.238M	$5.530M
YoY Change	87.99%	126.92%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$7.362M
YoY Change		94.01%
Total Short-Term Liabilities	$21.72M	$19.75M
YoY Change	74.54%	108.8%
LONG-TERM LIABILITIES
Long-Term Debt	$128.4K	$127.0K
YoY Change	-96.85%	-82.98%
Other Long-Term Liabilities		$1.584M
YoY Change		607.81%
Total Long-Term Liabilities	$128.4K	$127.0K
YoY Change	-96.85%	-82.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.72M	$19.75M
Total Long-Term Liabilities	$128.4K	$127.0K
Total Liabilities	$23.46M	$21.46M
YoY Change	28.6%	105.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$75.53M	-$76.44M
YoY Change	19.71%	25.06%
Common Stock	$82.21K	$82.21K
YoY Change	0.0%	97.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$15.32M
YoY Change
Total Liabilities & Shareholders Equity	$9.052M	$6.142M
YoY Change	-43.39%	315.92%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$972.9K	-$1.251M
YoY Change	-150.92%	-14.04%
Depreciation, Depletion And Amortization	$10.16K	$9.478K
YoY Change	-77.58%	234.79%
Cash From Operating Activities		$75.26K
YoY Change		242.09%
INVESTING ACTIVITIES
Capital Expenditures		$19.27K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities		-$19.27K
YoY Change		-103.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		16.45K
YoY Change		-95.88%
NET CHANGE
Cash From Operating Activities		75.26K
Cash From Investing Activities		-19.27K
Cash From Financing Activities		16.45K
Net Change In Cash		72.44K
YoY Change		-92.96%
FREE CASH FLOW
Cash From Operating Activities		$75.26K
Capital Expenditures		$19.27K
Free Cash Flow		$55.99K
YoY Change		154.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-52635
	dei	Entity Registrant Name EntityRegistrantName	CFN ENTERPRISES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1559541
	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 E. 8TH STREET
	dei	Entity Address City Or Town EntityAddressCityOrTown	WHITEFISH
	dei	Entity Address Country EntityAddressCountry	MT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59937
	dei	Country Region CountryRegion	833
	dei	City Area Code CityAreaCode	420
	dei	Local Phone Number LocalPhoneNumber	2636
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82210664	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	225415	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78744	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	20600	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20448	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1700632	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	942248	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1864703	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1796227	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3811350	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2837667	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	164412	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156343	usd
CY2024Q2	fil	Right Of Use Asset RightOfUseAsset	1860574	usd
CY2023Q4	fil	Right Of Use Asset RightOfUseAsset	2159043	usd
CY2024Q2	us-gaap	Deposit Assets DepositAssets	297269	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	297269	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	8810	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	8910	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	6142415	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5459232	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4440176	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3018531	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5529570	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3828063	usd
CY2024Q2	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2023Q4	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	235125	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	484212	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	7362408	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7272357	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2024Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	208000	usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	208000	usd
CY2024Q2	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	394726	usd
CY2023Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	822259	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	19750968	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17214385	usd
CY2024Q2	fil	Right Of Use Liability RightOfUseLiability	1584214	usd
CY2023Q4	fil	Right Of Use Liability RightOfUseLiability	1547410	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	126981	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	128443	usd
CY2024Q2	us-gaap	Liabilities Liabilities	21462163	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18890238	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82210664	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82210664	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82210664	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82210664	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	82210	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	82210	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61039808	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60909641	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76441770	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74422861	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15319748	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13431006	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6142415	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5459232	usd
CY2024Q2	us-gaap	Revenues Revenues	5893962	usd
CY2023Q2	us-gaap	Revenues Revenues	152301	usd
	us-gaap	Revenues Revenues	9738554	usd
	us-gaap	Revenues Revenues	265259	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	4878001	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	47484	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7029836	usd
	us-gaap	Cost Of Revenue CostOfRevenue	223675	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1015961	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	104817	usd
	us-gaap	Gross Profit GrossProfit	2708718	usd
	us-gaap	Gross Profit GrossProfit	41584	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1546949	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1703134	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3166743	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2125148	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1546949	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1703134	usd
	us-gaap	Operating Expenses OperatingExpenses	3166743	usd
	us-gaap	Operating Expenses OperatingExpenses	2125148	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-530988	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1598317	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-458025	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2083564	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	720424	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	37450	usd
	us-gaap	Interest Expense InterestExpense	1441035	usd
	us-gaap	Interest Expense InterestExpense	103501	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
CY2024Q2	us-gaap	Other Income OtherIncome	0	usd
CY2023Q2	us-gaap	Other Income OtherIncome	157502	usd
	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	157502	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	74	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	81	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	151	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	157	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-720350	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	142605	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1440884	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	76630	usd
CY2024Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1251338	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1455712	usd
	us-gaap	Profit Loss ProfitLoss	-1898909	usd
	us-gaap	Profit Loss ProfitLoss	-2006934	usd
CY2024Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	120000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	120000	usd
CY2024Q2	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-1311338	usd
CY2023Q2	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-1515712	usd
	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-2018909	usd
	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-2126934	usd
CY2024Q2	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.02
CY2023Q2	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.04
	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.02
	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.05
CY2024Q2	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	82210664	shares
CY2023Q2	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	40846664	shares
	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	82210664	shares
	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	40255331	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9172349	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-551222	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9183571	usd
CY2023Q2	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	405000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
CY2023Q2	fil	Warrants Issued In Connection With Note Payable WarrantsIssuedInConnectionWithNotePayable	185788	usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1455712	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8952396	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-13431006	usd
CY2024Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	71000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-647571	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14067577	usd
CY2024Q2	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	59167	usd
CY2024Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1251338	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15319748	usd
	us-gaap	Profit Loss ProfitLoss	-1898909	usd
	us-gaap	Profit Loss ProfitLoss	-2006934	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17910	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5663	usd
	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	298469	usd
	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	29488	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	432487	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	324744	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	16349	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1190871	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7855	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	68476	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-100	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8910	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3003152	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	351937	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-249087	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	5349	usd
	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	0	usd
	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	32500	usd
	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-390729	usd
	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-115493	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	278790	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-564277	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	0	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-608300	usd
	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	-25979	usd
	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25979	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	608300	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2119	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1175000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	236155	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	531056	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	130167	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	350000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-105988	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	991825	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	146823	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1035848	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32602	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246015	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1068450	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78744	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	20448	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	20128	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	99192	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	32602	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	225415	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1048166	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	20600	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	20284	usd
CY2024Q2	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	246015	usd
CY2023Q2	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	1068450	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Interest Paid InterestPaid	192500	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	120000	usd
	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	120000	usd
	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	0	usd
	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	185788	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	0	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	0	usd
	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	405000	usd
CY2019Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
CY2024Q2	fil	Working Capital Deficit WorkingCapitalDeficit	15939618	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76441770	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1898909	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Use of Estimates</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of consolidated financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p>
CY2024Q2	us-gaap	Inventory Net InventoryNet	1864703	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Concentration of Credit Risks</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company’s cash and restricted cash accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. From time-to-time, the Company’s bank balances exceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Concentrations</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company had two customers which accounted for 39% of accounts receivable as of June 30, 2024. During the three and six months ended June 30, 2024, one customer accounted for 52% and 33% of the Company’s revenues, respectively. The Company may be negatively affected by the loss of one of these customers.</p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Revenues Revenues	5893962	usd
CY2023Q2	us-gaap	Revenues Revenues	152301	usd
	us-gaap	Revenues Revenues	9738554	usd
	us-gaap	Revenues Revenues	265259	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2024Q2	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2024Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	208000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	9208000	usd
CY2024Q2	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	134060	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	175340	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	297269	usd
CY2024Q2	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedGoodwill	8676430	usd
CY2024Q2	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseAsset	2272059	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	48430	usd
CY2024Q2	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Liability Current BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseLiabilityCurrent	-538243	usd
CY2024Q2	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Liability Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseLiabilityNoncurrent	-1760485	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	9208000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2459000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2282313	usd
	fil	Business Acquisition Proforma Earnings Per Share BusinessAcquisitionProformaEarningsPerShare	-0.06
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	252952	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	226973	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	88540	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70630	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	164412	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156343	usd
CY2024Q2	us-gaap	Depreciation Depreciation	9478	usd
CY2023Q2	us-gaap	Depreciation Depreciation	2831	usd
	us-gaap	Depreciation Depreciation	17910	usd
	us-gaap	Depreciation Depreciation	5664	usd
CY2021Q2	us-gaap	Notes Payable NotesPayable	2957000	usd
CY2021Q2	fil	Outstanding Amount OutstandingAmount	158625	usd
CY2021Q2	fil	Balance Paid Per Month BalancePaidPerMonth	20000	usd
CY2021Q2	fil	Total Paid Per Month TotalPaidPerMonth	138625	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	250000	usd
CY2021Q4	fil	Accrued Interest Rate AccruedInterestRate	0.12	pure
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7362408	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8772	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8772	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8772	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	100665	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	7489389	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	7362408	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Dividends Paidinkind DividendsPaidinkind	120000	usd
	us-gaap	Dividends Paidinkind DividendsPaidinkind	120000	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
CY2024Q2	fil	Right Of Use Asset RightOfUseAsset	1860574	usd
CY2023Q4	fil	Right Of Use Asset RightOfUseAsset	2159043	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	394726	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	822259	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1584214	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1547410	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1978940	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2369669	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2024Q2	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2023Q4	fil	Due To Related Party DueToRelatedParty	501140	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	130167	usd

Files In Submission

Name	View Source	Status
0001096906-24-001665-index-headers.html	Edgar Link	pending
0001096906-24-001665-index.html	Edgar Link	pending
0001096906-24-001665.txt	Edgar Link	pending
0001096906-24-001665-xbrl.zip	Edgar Link	pending
cfn_ex31z1.htm	Edgar Link	pending
cfn_ex32z1.htm	Edgar Link	pending
cnfn-20240630.htm	Edgar Link	pending
cnfn-20240630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
cnfn-20240630_def.xml	Edgar Link	unprocessable
cnfn-20240630_lab.xml	Edgar Link	unprocessable
cnfn-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cnfn-20240630_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cnfn-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNFN
CFN Enterprises Inc. Stock $cnfn

2024 Q3 Form 10-Q Financial Statement

#000109690624001665 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN CFN Enterprises Inc. Stock $cnfn

2024 Q3 Form 10-Q Financial Statement

#000109690624001665 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN
CFN Enterprises Inc. Stock $cnfn